Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204Multicenter Study Published on 2022-12-312023-06-09 Journal: Supportive Care in Cancer [Category] B형 간염, [키워드] antineoplastic agents Hepatitis B virus hepatitis C virus HIV Infection reactivation Latent infection. [DOI] 10.1007/s00520-022-07525-1 PMC 바로가기 [Article Type] Multicenter Study
Potential interactions between antineoplastic agents and medicines used to treat Covid-19Article Published on 2022-12-012022-11-15 Journal: Journal of Oncology Pharmacy Practice [Category] 치료제, [키워드] accounted Affect antineoplastic agents antineoplastic drug Baricitinib benefit Cancer Chloroquine Combination conducted COVID-19 disease drug drug combinations drug-drug interaction Drug-drug interactions Drug–drug interactions drug–drug interactions. Health Hydroxychloroquine identify Interaction interaction effect interactions involved Lexicomp Medicine Modification outcomes Patient Patients with cancer pharmacokinetic pharmacological intervention plasma concentration Potential professional risk severity therapeutic treat Treatment tyrosine kinase inhibitor was increased [DOI] 10.1177/10781552211040494 PMC 바로가기
Challenges of cancer immunotherapy and chemotherapy during the COVID-19 pandemicReview Published on 2022-10-012023-07-07 Journal: Tumori [Category] COVID19(2023년), [키워드] antineoplastic agents COVID-19 drug-related side effects and adverse reactions immunotherapy. pandemic SARS-CoV-2 [DOI] 10.1177/03008916211063939 PMC 바로가기 [Article Type] Review
Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysisResearch Article Published on 2021-11-252022-10-30 Journal: Infectious Agents and Cancer [Category] COVID-19, [키워드] 95% CI acute respiratory syndrome adjusted Analysis analyzed Androgen antagonists Androgen receptor antagonists antineoplastic agents association Cohort Control coronavirus COVID-19 death Deprivation died Final GnRH Impact less Mortality MOST Patient patients hospitalized patients with COVID-19 performed previous study Prostate cancer protective factor public health reduce reduced risk reductions in Result Retrospective analysis robust supplementary material survival therapy treat Treatment variable were used [DOI] 10.1186/s13027-021-00406-y PMC 바로가기 [Article Type] Research Article
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?Original Articles Published on 2021-05-072022-10-29 Journal: Journal of Oncology Pharmacy Practice [Category] COVID-19, SARS, [키워드] Affect age anticancer antineoplastic agents Cancer cancer patient cancer treatment Chemotherapy COVID COVID-19 COVID-19 infected patient COVID-19 infection COVID-19 pandemic demographic characteristics determine diagnosis of cancer disease Factor hospital Hospitalization Immunotherapy infected patient infection rate lung cancer male material metastatic stage morbidity and mortality non-infected parameter Patient patients patients treated Patients with cancer Prognosis receiving Result risk statistically significant targeted therapy the median the patient Therapies therapy Treatment were infected with COVID-19 [DOI] 10.1177/10781552211015762 PMC 바로가기 [Article Type] Original Articles